Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Kieff, Elliott
Item TypeName
Academic Article Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.
Academic Article An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases.
Academic Article Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines.
Academic Article The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.
Academic Article An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.
Academic Article The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines.
Academic Article Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.
Academic Article Latent membrane protein 1 is dispensable for Epstein-Barr virus replication in human embryonic kidney 293 cells.
Academic Article Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus.
Academic Article IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
Academic Article Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.
Academic Article A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.
Academic Article In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2).
Academic Article Leukocyte migration inhibition demonstrates a human T-cell response to a membrane protein expressed in latent Epstein-Barr virus infection.
Academic Article Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
Academic Article The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.
Academic Article Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Academic Article The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Academic Article Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.
Academic Article Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.
Academic Article Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.
Academic Article Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.
Academic Article A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
Academic Article The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
Academic Article Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription.
Academic Article cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site.
Academic Article An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.
Academic Article Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
Academic Article The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.
Academic Article Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.
Academic Article Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.
Academic Article Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.
Academic Article Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin.
Academic Article The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB.
Academic Article Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.
Academic Article Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.
Academic Article Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
Academic Article Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
Academic Article EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Academic Article IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3.
Academic Article Two related Epstein-Barr virus membrane proteins are encoded by separate genes.
Academic Article Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein.
Academic Article Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Academic Article Recognition of EBV plasma membrane protein expressed on murine cells after gene transfer.
Academic Article Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation.
Academic Article Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.
Academic Article Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
Academic Article Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
Academic Article An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.
Academic Article Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.
Academic Article Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors.
Academic Article A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
Academic Article Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.
Academic Article Intracellular forms of human NOTCH1 interact at distinctly different levels with RBP-jkappa in human B and T cells.
Academic Article Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40.
Academic Article Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
Concept Membrane Proteins
Grant Screening of Epstein Barr Virus Replication (RMI)
Grant Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation
Grant Epstein-Barr Virus LMP1-Mediated Oncogenecity
Grant MOLECULAR BIOLOGY OF EPSTEIN-BARR VIRUS INFECTION
Grant Targeting Epstein-Barr Virus Super-Enhancer
Grant Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
Grant EBV MEMBRANE PROTEIN: TRANSFORMATION AND LATENCY
Search Criteria
  • Membrane Proteins
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.